[Amalgam: a risk assessment using a review of the latest literature through 2005].
Halbach
S
S
Institut für Toxikologie, GSF-Forschungszentrum, Oberschleissheim.
D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000378:metabolism; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003723:Dental Amalgam / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008628:Mercury / Q000009:adverse effects* / Q000493:pharmacokinetics; D008630:Mercury Poisoning / Q000175:diagnosis / Q000209:etiology*; D019636:Neurodegenerative Diseases / Q000139:chemically induced* / Q000378:metabolism; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
D003723:Dental Amalgam; D008628:Mercury